ArticleClinical immunology (Orlando, Fla.)2015

Cbl-b-deficient mice express alterations in trafficking-related molecules but retain sensitivity to the multiple sclerosis therapeutic agent, FTY720.

Mai Fujiwara et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.